Free Submission Public Relations &
Deutsch English


"EpiCast Report: Psoriasis - Epidemiology Forecast to 2022" Published

Print article Print article
2013-04-21 17:59:10 - Recently published research from GlobalData, "EpiCast Report: Psoriasis - Epidemiology Forecast to 2022", is now available at Fast Market Research

Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes and of all ages and races/ethnicities. The global prevalence of psoriasis varies geographically, with the disease being more prevalent in the colder areas of the north, and less prevalent in the tropics and warmer regions of the world (Weller et al., 2008). In European countries, psoriasis is more prevalent in residents of the colder central regions and less prevalent in residents of the southern regions. In some Asian countries, such as India, the prevalence of psoriasis is highest in the northern parts of the country. In contrast to India, China shows no difference in prevalence between the northern and southern

regions (Bedi, 1995; Ding et al., 2012; Kawada et al., 2003; Naldi et al., 2004; Saraceno et al., 2006). In addition to the north-to-south prevalence gradient observed within most countries, the prevalence of psoriasis also varies among different countries. Globally, the prevalence of psoriasis varies from as low as 0.03% in Japan to as high as 3.15% in the US (Ding et al., 2012; Kawada et al., 2003). Differences in the reported prevalence between countries may be attributable to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies (Bedi, 1995; Ding et al., 2012; Gelfand et al., 2005b).

Full Report Details at
- ..


* The Psoriasis EpiCast Report provides an overview of the risk factors and global trends of psoriasis in the nine major markets (the US, France, Germany, Italy, Spain, the UK, Japan, China, and India).
* It includes a 10-year epidemiology forecast of the prevalent cases of psoriasis segmented by sex and age (by five-year increments, beginning at age 15 years and ending at =85 years) in the 9MM.

Reasons to buy

* Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
* Quantify patient populations in the global psoriasis market to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for psoriasis therapeutics in each of the markets covered.

Report Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Upcoming Reports
3 Epidemiology
3.1 Risk Factors and Comorbidities
3.1.1 Family history of psoriasis increases the risk of developing the disease by nearly 20 times
3.1.2 Obesity doubles the risk of psoriasis
3.1.3 Smoking, combined with other risk factors, increases the risk for psoriasis up to nine times
3.1.4 Psoriatic arthritis is present in up to 40.0% of all psoriasis patients
3.1.5 Nearly half of all psoriasis patients report elevated stress levels, depression, and thoughts of suicide
3.2 Global Trends
3.2.1 US
3.2.2 5EU
3.2.3 Japan
3.2.4 China
3.2.5 India
3.3 Forecast Methodology
3.3.1 Sources Used
3.3.2 Forecast Assumptions and Methods
3.3.3 Sources Not Used
3.4 Epidemiology Forecast (2012-2022)
3.4.1 Prevalent Cases of Psoriasis
3.4.2 Age-Specific Prevalent Cases of Psoriasis
3.4.3 Sex-Specific Prevalent Cases of Psoriasis
3.4.4 Age-Standardized Prevalence of Psoriasis
3.5 Discussion
3.5.1 Conclusions on Epidemiology Trends
3.5.2 Limitations of Analysis
3.5.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis
4.2.4 Global Head of Healthcare
4.3 About GlobalData
4.4 About EpiCast
4.5 Contact Us
4.6 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Risk Factors and Comorbidities Associated with Psoriasis
Table 2: 9MM, Sources of Psoriasis Epidemiology Data Used for the Forecast
Table 3: 9MM, Prevalent Cases of Psoriasis, Ages ≥15 Years, Men and Women, N, 2012-2022
Table 4: 9MM, Age-Specific Prevalent Cases of Psoriasis, Ages ≥15 Years, Men and Women, N (Row %), 2012
Table 5: 9MM, Sex-Specific Prevalent Cases of Psoriasis, Ages ≥15 Years, N (Row %), 2012

List of Figures

1.2 List of Figures
Figure 1: 9MM, Prevalent Cases of Psoriasis, Ages ≥15 Years, Men and Women, N, 2012-2022
Figure 2: 9MM, Age-Specific Prevalent Cases of Psoriasis, Ages ≥15 Years, Men and Women, N, 2012
Figure 3: 9MM, Sex-Specific Prevalent Cases of Psoriasis, Ages ≥15 Years, N, 2012
Figure 4: 9MM, Age-Standardized Prevalence of Psoriasis, Ages ≥15 Years, Men and Women, %, 2012

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact